- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-3-3-mer
 - Ligands
 - 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.14: 3 residues within 4Å:- Chain A: N.693
 - Chain B: I.778, Y.780
 
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: A.690, N.1058
 
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.641
 
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: N.600, T.602
 - Chain B: Q.820
 
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: E.265, N.266
 - Chain C: K.542
 
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain A: N.107, T.109, N.110, E.136
 
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain B: N.693
 
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain B: A.690, E.1056, N.1058
 
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain B: N.600, E.603, Q.628
 - Chain C: Q.820
 
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain B: N.264, E.265, N.266
 
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain B: N.315, P.563, Q.564, L.566
 
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: Y.780
 - Chain C: N.693
 
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain A: Q.820, D.823
 - Chain C: N.600, T.602, E.603
 
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.264, E.265, N.266
 
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain C: N.107, T.109, N.110, V.112
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Zhou, T. et al., Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science (2022)
          


 - Release Date
 - 2022-03-30
 - Peptides
 - Spike glycoprotein: ABC
Heavy chain of antibody A19-46.1: DHJ
Light chain of antibody A19-46.1: EIK
heavy chain of antibody B1-182.1: FLN
Light chain of antibody B1-182.1: GMO - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DH
HJ
ME
EI
LK
NF
JL
ON
FG
KM
PO
G 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-3-3-mer
 - Ligands
 - 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Zhou, T. et al., Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science (2022)
          


 - Release Date
 - 2022-03-30
 - Peptides
 - Spike glycoprotein: ABC
Heavy chain of antibody A19-46.1: DHJ
Light chain of antibody A19-46.1: EIK
heavy chain of antibody B1-182.1: FLN
Light chain of antibody B1-182.1: GMO - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DH
HJ
ME
EI
LK
NF
JL
ON
FG
KM
PO
G